Hakala M T, Slocum H K, Gryko G J
J Cell Physiol. 1975 Oct;86(2 Pt 1):281-91. doi: 10.1002/jcp.1040860212.
N6-(delta2-Isopentenyl)adenosine (IPAR) inhibited severely the incorporation of uridine and cytidine into S-180 cells in culture. When IPAR and the nucleosides were simultaneously present in the medium the inhibition was competitive (Ki 3.4 muM) and indicated inhibition of transport. However, the inhibition occurred even in the absence of extracellular IPAR if the cells had been preincubated with IPAR. Since 5'-IPAMP was the product which accumulated in large quantities in S-180 cells when incubated with IPAR, the effects of this AMP analog of the intracellular metabolism of uridine had to be considered. No direct correlation between the amount of intracellular IPAMP and the degree of inhibition of uridine utilization was observed and the relative distribution of uridine nucleotides in the acid soluble pool of the cells was unaltered in cells treated with IPAR. Also, IPAMP was not an inhibitor of uridine kinase in a cell free system nor was the activity of this enzyme affected by treatment of cells with IPAR. In addition, a profound inhibition of uridine utilization was also observed in a resistant subline of S-180 cells, which is unable to form IPAMP. These data suggest that IPAMP was not the inhibitory agent. Furthermore, the observation that the inhibition in both sensitive and resistant cells was caused even by a 15-second exposure to 100 muM IPAR, followed by rinsing, suggests that IPAR itself is the effective agent. It is concluded that IPAR exerts its inhibitory effect on uridine and cytidine utilization by becoming lodged in the cell membrane and thereby preventing the passage of these nucleosides into the cells. It is also shown that the inhibition of uridine and cytidine utilization by IPAR and by other potent nucleoside uptake inhibitors is unrelated to inhibition of growth or RNA-synthesis when the cells do not depend on an extracellular source of a nucleoside for growth.
N6-(δ2-异戊烯基)腺苷(IPAR)严重抑制尿苷和胞苷掺入培养的S-180细胞。当IPAR和核苷同时存在于培养基中时,抑制作用具有竞争性(Ki为3.4 μM),表明是对转运的抑制。然而,如果细胞先用IPAR预孵育,即使在没有细胞外IPAR的情况下也会发生抑制。由于5'-IPAMP是S-180细胞与IPAR一起孵育时大量积累的产物,因此必须考虑这种AMP类似物对尿苷细胞内代谢的影响。未观察到细胞内IPAMP的量与尿苷利用抑制程度之间的直接相关性,在用IPAR处理的细胞中,细胞酸溶性池中尿苷核苷酸的相对分布未改变。此外,IPAMP在无细胞系统中不是尿苷激酶的抑制剂,该酶的活性也不受IPAR处理细胞的影响。另外,在不能形成IPAMP的S-180细胞抗性亚系中也观察到尿苷利用的显著抑制。这些数据表明IPAMP不是抑制剂。此外,即使对敏感细胞和抗性细胞进行15秒的100 μM IPAR处理然后冲洗也会引起抑制作用,这一观察结果表明IPAR本身就是有效剂。得出的结论是,IPAR通过滞留在细胞膜中从而阻止这些核苷进入细胞,对尿苷和胞苷的利用发挥抑制作用。还表明,当细胞生长不依赖核苷的细胞外来源时,IPAR和其他有效的核苷摄取抑制剂对尿苷和胞苷利用的抑制与生长抑制或RNA合成抑制无关。